Memorial Sloan Kettering Cancer Center

FEATURING Gunjan Shah

MSKCC COVID-19 Experience: What Are the Basic Mechanisms of Viral Entry, Replication & Transmission? How Does Dysfunctional Immune Response Contribute to Disease Progression? Is Remdesivir Still the SoC for Severe/Critically-Ill Patients?

FEATURING Tobias Hohl

Cancer Care & COVID-19 at MSKCC: What Are the Disease Severity Risk Factors Based on Treatment Modalities? Are There Correlations With Advanced Age and Comorbidities?

FEATURING Elizabeth Robilotti

COVID-19 & Critical Care at MSKCC: Could We Have Prepared to Rapidly Approach This Illness? What Are the Ways to Expand/Adjust ICU Capacity and Implement Advanced Informatics Infrastructure While Saving Costs?

FEATURING Neil Halpern

MSKCC Updates on COVID-19 Prevention, Testing & Safety: What Does the Current Evidence for Viral Transmission Suggest? What Are the Key Steps for Prevention? How Can We Deflect Nosocomial Spread?

FEATURING Mini Kamboj

MSKCC Highlights on COVID-19 & Surgical Outcomes: Elective vs. Essential Surgery - What Is the Difference? Does Cancer Surgery Delay Impact Different Solid Tumors? Is Infection More Dangerous in the Post-Operative Setting?

FEATURING Jeffrey Drebin

MSKCC Updates on Telemedicine/Cohort Monitoring & COVID-19 Testing for Chemotherapy: Can We Leverage Technology to Use Virtual Care? What Are the Guidelines for Outpatient Treatment and Resumption of Antineoplastic Therapy?

FEATURING Diane Reidy-Lagunes

MSKCC Expert Discussion on COVID-19 & Cancer: Should Anticoagulants Be Used in the ICU for Every Patient? Is Telemedicine Screening Preventing Earlier Disease Detection? What Is the Impact of COVID-19 on Autoimmune Diseases?

Multiple Myeloma & COVID-19 May Update: What Are The New Treatment Guidelines & Key Takeaways from the Pandemic?

FEATURING Ola Landgren

Perspectives on COVID-19 and Multiple Myeloma Care: New York City, End of March 2020

FEATURING Ola Landgren

Impact of COVID-19 on Recipients of HCT and CAR T-Cells

MSKCC COVID-19 Experience: What Are the Basic Mechanisms of Viral Entry, Replication & Transmission? How Does Dysfunctional Immune Response Contribute to Disease Progression? Is Remdesivir Still the SoC for Severe/Critically-Ill Patients?

Cancer Care & COVID-19 at MSKCC: What Are the Disease Severity Risk Factors Based on Treatment Modalities? Are There Correlations With Advanced Age and Comorbidities?

COVID-19 & Critical Care at MSKCC: Could We Have Prepared to Rapidly Approach This Illness? What Are the Ways to Expand/Adjust ICU Capacity and Implement Advanced Informatics Infrastructure While Saving Costs?

MSKCC Updates on COVID-19 Prevention, Testing & Safety: What Does the Current Evidence for Viral Transmission Suggest? What Are the Key Steps for Prevention? How Can We Deflect Nosocomial Spread?

MSKCC Highlights on COVID-19 & Surgical Outcomes: Elective vs. Essential Surgery - What Is the Difference? Does Cancer Surgery Delay Impact Different Solid Tumors? Is Infection More Dangerous in the Post-Operative Setting?

MSKCC Updates on Telemedicine/Cohort Monitoring & COVID-19 Testing for Chemotherapy: Can We Leverage Technology to Use Virtual Care? What Are the Guidelines for Outpatient Treatment and Resumption of Antineoplastic Therapy?

MSKCC Expert Discussion on COVID-19 & Cancer: Should Anticoagulants Be Used in the ICU for Every Patient? Is Telemedicine Screening Preventing Earlier Disease Detection? What Is the Impact of COVID-19 on Autoimmune Diseases?

Multiple Myeloma & COVID-19 May Update: What Are The New Treatment Guidelines & Key Takeaways from the Pandemic?

Perspectives on COVID-19 and Multiple Myeloma Care: New York City, End of March 2020